Nowicki P, Kłos M
Pol J Pharmacol Pharm. 1980 Jan-Feb;32(1):77-84.
Present state of investigations on the noxious effects of contact of blood and its preparations with products made of polyvinyl chloride (PVC) is reviewed. Di-2-ethylhexyl pthalate (DEHP), used for softening of PVC employed for medical purposes, has harmful effect on certain cells and possibly cumulates in the organism. In certain cases (massive transfusion) large amounts of DEHP may penetrate into the organism in quantities exceeding the tolerance of the organism and becoming an additional health-endangering factor. DEHP during storage of blood and its preparations has high migration ability parallelling the storage time, and unequal distribution in different blood components. Although there are no reliable evidence of the risk connected with the using of blood stored in PCV containers, presence of DEHP in the blood during transfusions and its possible effect in interaction with other factors on the patient's condition should be considered. It seems that in making containers for blood and blood preparations PCV should be replaced with other materials or the softeners added to PCV should be replaced with less toxic ones.
综述了血液及其制品与聚氯乙烯(PVC)制品接触产生有害影响的研究现状。用于医疗用途PVC软化的邻苯二甲酸二(2-乙基己基)酯(DEHP)对某些细胞有有害影响,并且可能在体内蓄积。在某些情况下(大量输血),大量的DEHP可能以超过机体耐受量的数量渗入机体,成为另一个危害健康的因素。DEHP在血液及其制品储存期间具有与储存时间平行的高迁移能力,并且在不同血液成分中分布不均。尽管没有可靠证据表明使用储存在PVC容器中的血液存在风险,但输血期间血液中DEHP的存在及其与其他因素相互作用对患者病情的可能影响仍应予以考虑。似乎在制造血液和血液制品容器时,PVC应被其他材料替代,或者添加到PVC中的软化剂应被毒性较小的软化剂替代。